09.04.2015 Views

Bioanalytical Methods Validation for Human Studies - Pharmanet

Bioanalytical Methods Validation for Human Studies - Pharmanet

Bioanalytical Methods Validation for Human Studies - Pharmanet

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Draft — Not <strong>for</strong> Implementation<br />

<strong>for</strong> the development of SOPs <strong>for</strong> evaluation of an analyte’s stability in a biological<br />

matrix (Timm 1985). Whatever approach is used, the SOPs should clearly<br />

describe the statistical method and rules employed. Additional validation may<br />

include investigation of samples from dosed subjects.<br />

F. Acceptance Criteria<br />

An analytical method is considered fully validated when it meets the following criteria:<br />

Precision: The between-batch CVs <strong>for</strong> low, medium, and high concentrations should be<br />

#15%, and #20% <strong>for</strong> the LOQ QC, using a minimum of three batches.<br />

Accuracy: The between-batch mean value should be within ±15% of the nominal value at<br />

low, medium, and high QC concentrations and should not deviate by more than ±20% at<br />

the LOQ.<br />

Sensitivity: The lowest standard should be accepted as the limit of quantitation of the<br />

method if the between-batch CV at the LOQ QC is #20%.<br />

Specificity: The responses of interfering peaks at the retention time of the analyte should<br />

be less than 20% of the response of an LOQ standard. Responses of interfering peaks at<br />

the retention time of the internal standard should be #5% of the response of the<br />

concentration of the internal standard to be used in studies.<br />

Stability: Long-term, short-term, freeze and thaw, stock solution, and autosampler<br />

stability data should meet the criteria specified in the SOP.<br />

V. IN-STUDY VALIDATION<br />

Assays of all samples of an analyte in a biological matrix should be completed within the time<br />

period <strong>for</strong> which stability data are available. In general, analysis of biological samples can be done<br />

with a single determination without duplicate or replicate analysis if the assay method has<br />

acceptable variability as defined by validation data. This is true <strong>for</strong> procedures where precision<br />

and accuracy variabilities routinely fall within acceptable tolerance limits. For a difficult<br />

procedure with a labile analyte, where high precision and accuracy specifications may be difficult<br />

to achieve, duplicate or even triplicate analyses may be recommended <strong>for</strong> better estimate of<br />

analyte.<br />

j:\!guidance\2578dft.wpd<br />

12/14/98 9

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!